• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response.

作者信息

Behren Andreas, Thompson Erik W, Anderson Robin L, Ferrao Petranel T

机构信息

School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia.

Cancer Immunobiology Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.

出版信息

Front Oncol. 2019 May 7;9:276. doi: 10.3389/fonc.2019.00276. eCollection 2019.

DOI:10.3389/fonc.2019.00276
PMID:31134142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6514092/
Abstract
摘要

相似文献

1
Editorial: Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response.社论：癌症可塑性与微环境：对免疫和治疗反应的影响
Front Oncol. 2019 May 7;9:276. doi: 10.3389/fonc.2019.00276. eCollection 2019.
2
Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.EMT 与 PD-L1 信号转导之间的通讯：肿瘤免疫逃逸的新见解。
Cancer Lett. 2020 Jan 1;468:72-81. doi: 10.1016/j.canlet.2019.10.013. Epub 2019 Oct 9.
3
New insights into the role of EMT in tumor immune escape.上皮-间质转化（EMT）在肿瘤免疫逃逸中作用的新见解。
Mol Oncol. 2017 Jul;11(7):824-846. doi: 10.1002/1878-0261.12093. Epub 2017 Jun 27.
4
Tumor plasticity interferes with anti-tumor immunity.肿瘤可塑性会干扰抗肿瘤免疫。
Crit Rev Immunol. 2014;34(2):91-102. doi: 10.1615/critrevimmunol.2014010183.
5
Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response.肿瘤浸润性免疫抑制细胞在癌细胞可塑性、肿瘤进展及治疗反应中的作用
Cancer Microenviron. 2019 Dec;12(2-3):119-132. doi: 10.1007/s12307-019-00232-2. Epub 2019 Oct 3.
6
Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.肿瘤微环境与非编码RNA作为上皮-间质转化和癌症转移的共同驱动因素
Dev Dyn. 2018 Mar;247(3):405-431. doi: 10.1002/dvdy.24548. Epub 2017 Sep 18.
7
Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells.上皮-间质转化驱动的乳腺癌免疫微环境变化及癌细胞的治疗反应的后果
J Clin Med. 2019 May 9;8(5):642. doi: 10.3390/jcm8050642.
8
Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer.肺癌中免疫细胞促进上皮-间质转化的分子机制及免疫治疗进展
J Oncol. 2019 Aug 19;2019:7475364. doi: 10.1155/2019/7475364. eCollection 2019.
9
Editorial: The Role of the EMT Program in Regulating the Immune Response in Carcinoma.社论：急救医疗技术员项目在调控癌症免疫反应中的作用
Front Immunol. 2022 May 30;13:940164. doi: 10.3389/fimmu.2022.940164. eCollection 2022.
10
Decoding cancer's camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade.解码癌症的伪装：上皮-间质可塑性与免疫检查点阻断耐药性
Cancer Drug Resist. 2020 Oct 12;3(4):832-853. doi: 10.20517/cdr.2020.41. eCollection 2020.

引用本文的文献

1
Engineered in vitro tumor models for cell-based immunotherapy.基于细胞的免疫疗法的体外肿瘤模型构建。
Acta Biomater. 2021 Sep 15;132:345-359. doi: 10.1016/j.actbio.2021.03.076. Epub 2021 Apr 20.
2
Integrating the Tumor Microenvironment into Cancer Therapy.将肿瘤微环境纳入癌症治疗。
Cancers (Basel). 2020 Jun 24;12(6):1677. doi: 10.3390/cancers12061677.

本文引用的文献

1
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.上皮-间质转化的机制新见解及其对癌症的影响。
Nat Rev Mol Cell Biol. 2019 Feb;20(2):69-84. doi: 10.1038/s41580-018-0080-4.
2
The hallmarks of successful anticancer immunotherapy.成功的抗癌免疫疗法的特征。
Sci Transl Med. 2018 Sep 19;10(459). doi: 10.1126/scitranslmed.aat7807.
3
EMT in cancer.肿瘤中的 EMT。
Nat Rev Cancer. 2018 Feb;18(2):128-134. doi: 10.1038/nrc.2017.118. Epub 2018 Jan 12.
4
New insights into the role of EMT in tumor immune escape.上皮-间质转化（EMT）在肿瘤免疫逃逸中作用的新见解。
Mol Oncol. 2017 Jul;11(7):824-846. doi: 10.1002/1878-0261.12093. Epub 2017 Jun 27.
5
Cancer Immunotherapy: Whence and Whither.癌症免疫疗法：起源与发展方向
Mol Cancer Res. 2017 Jun;15(6):635-650. doi: 10.1158/1541-7786.MCR-16-0427. Epub 2017 Mar 29.
6
Elements of cancer immunity and the cancer-immune set point.癌症免疫的要素和癌症免疫基准。
Nature. 2017 Jan 18;541(7637):321-330. doi: 10.1038/nature21349.
7
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.与黑色素瘤中PD-1阻断获得性耐药相关的突变
N Engl J Med. 2016 Sep 1;375(9):819-29. doi: 10.1056/NEJMoa1604958. Epub 2016 Jul 13.
8
Tumor plasticity interferes with anti-tumor immunity.肿瘤可塑性会干扰抗肿瘤免疫。
Crit Rev Immunol. 2014;34(2):91-102. doi: 10.1615/critrevimmunol.2014010183.
9
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.抗 PD-1 抗体在癌症中的安全性、活性和免疫相关性。
N Engl J Med. 2012 Jun 28;366(26):2443-54. doi: 10.1056/NEJMoa1200690. Epub 2012 Jun 2.
10
The immune contexture in human tumours: impact on clinical outcome.人类肿瘤中的免疫结构：对临床结果的影响。
Nat Rev Cancer. 2012 Mar 15;12(4):298-306. doi: 10.1038/nrc3245.